Effect of PATient Education Related to CV Risk factOrs in Type 2 Diabetes Mellitus(Patrol).
PATROL
A Multi-center, Prospective, Observational Study to Assess the Effect of Patient Education Related to CV Risk Factors in Type 2 Diabetes Mellitus
1 other identifier
observational
4,045
1 country
7
Brief Summary
This study will address the proportion of achievement patients in treatment target goal on glycemic control, hypertension and hyperlipidemia according to ADA 2008 guideline, among outpatients coming to the Korean primary care nationwide.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2009
Shorter than P25 for all trials
7 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 28, 2009
CompletedFirst Posted
Study publicly available on registry
May 1, 2009
CompletedStudy Start
First participant enrolled
May 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2009
CompletedNovember 3, 2009
November 1, 2009
April 28, 2009
November 2, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Proportion of achievement patients in treatment target goal on glycemic control, hypertension and hyperlipidemia according to ADA 2008 guideline
At baseline and Endpiont (after 2months)
Secondary Outcomes (1)
The treatment goal of risk factors is based on ADA guideline.
At baseline and Endpiont (after 2months)
Study Arms (1)
1
Type II DM and Hypertension and/or Hyperlipidemia
Eligibility Criteria
Type II DM and Hypertension and/or Hyperlipidemia
You may qualify if:
- Patients who had been diagnosed with type II diabetes mellitus
- Patients with hypertension and / or hyperlipidemia
- Patients who had agreed to Informed
You may not qualify if:
- Patients who had been diagnosed with type I diabetes mellitus
- Patients with neither hypertension and hyperlipidemia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- AstraZenecalead
Study Sites (7)
Research Site
Busan, South Korea
Research Site
Cheiju, South Korea
Research SIte
Daegu, South Korea
Research Site
Gwangju, South Korea
Research Site
Hongseong, South Korea
Research Site
Seoul, South Korea
Research Site
Sungman, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Joonwoo Bahn
ASTRAZENECA, Korea Medical Department
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
April 28, 2009
First Posted
May 1, 2009
Study Start
May 1, 2009
Study Completion
October 1, 2009
Last Updated
November 3, 2009
Record last verified: 2009-11